Let's descover Top 5 in everything you are looking for in various fields, such as restaurants, stores, hotels, products and so on, all sorted upon users experiences and trials...
05-01-2022 - 10:46 pm
China’s booming pharmaceutical industry has been rapidly expanding to become the second largest pharmaceutical market globally. The following are the top five Chinese pharma companies from 2018, with revenues reaching over USD 1 billion.

Beijing Four Rings Bio-Pharmaceutical Co.,Ltd.



Beijing Four Rings Biopharmaceutical Co., Ltd., former military enterprise (Sihuan Bioengineering Plant) subordinated to Institute of Biotechnology of the Academy of Military Medical Sciences, is a new high-tech enterprise integrating science, industry and trade as a whole. Founded in 1988, it has committed itself to the research, development, production and sales of bio-engineering technical products as one of the first group of gene engineering products manufacturers of MOH.
Address: 5 Jian'an St, Daxing District, Beijing, China
web site : http://www.bjshsw.com.cn/index.php

Bath Utensil (China) Pharmaceutical Industry Limited Company



Eisai has been smoothly developing its business in China since the early 1990s, starting with the establishment of Shenyang Eisai Pharmaceutical Co., Ltd. in 1991, followed by the establishment of Eisai Suzhou Pharmaceutical Co., Ltd, and was officially renamed Eisai China Inc. in 2002. With the development of its business in China
adress: Shanghai, Jing'an District, Shaanxi N Rd, 20th Floor, Building 1, Hang Lung Plaza
web site:https://www.eisai.com.cn/en/index_en.php



Sinopharm Group



Sinopharm Group, the largest member of the China National Pharmaceutical Group, was officially established in 2003. The company engages in the research and development, manufacturing, distribution, and marketing of medicine and other healthcare products. Sinopharm Group manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China. The Group is considered the largest wholesaler and retailer of pharmaceutical and healthcare products in China, as well as a leading supply-chain service provider. The company listed on the Hong Kong Stock Exchange (HKEx) in 2009. Its total sales in 2018 reached more than USD 48 billion, far outpacing the other companies in the top 10 list.
Address: No.20 Zhichun
Road, Haidian District, Beijing, China
Postal Code: 100191
Tel:86-10-82287727
Fax: 86-10-62033332
Website: http://www.sinopharm.com

Shanghai Pharmaceuticals



Shanghai Pharmaceuticals Holding Co., Ltd., headquartered in Shanghai and led by chairman Da Wei Liu, was founded in 1994 as an investment holding company which researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China. The company focuses on various therapeutic areas, including digestion, immune system, cardiovascular, anti-infection, nervous system, and oncology, as well as musculoskeletal system, and metabolism. Shanghai Pharmaceuticals produces approximately 800 varieties of drugs and oversees distribution, storage, logistics, and other supply chain solutions. In addition, it operates a network of over 1,800 retail pharmacy stores in 16 provinces and engages in manufacturing of medical equipment. Company sales reached more than USD 22 billion in 2018.
adress : Shanghai Pharmaceutical Mansion No.200 Taicang Road SHANGHAI، SHA 200020، CN
Website:https://pharmaboardroom.com/directory/shanghai-pharmaceuticals/


Jiangsu Hengrui Medicine



Jiangsu Hengrui Medicine was established in 1970 and has grown into the largest research and manufacturing base of antineoplastics and surgical medicine in China. The company engages in the manufacturing and distribution of pharmaceutical tablets, injections and raw materials, and its portfolio includes antineoplastic drugs for cancer treatment, angiomyocardiac drugs, contrast agents, and antibiotics. Jiangsu Hengrui is headquartered in Lianyungang, Jiangsu Province, and has R&D and production centers in Shanghai, Chengdu and New Jersey. Since its founding, the company has grown to more than 8,000 employees and sales revenue exceeded USD 17 million in 2018. Its injection products were the first to be approved by the FDA and the European Union, allowing them to be sold in Europe and the United States. Jiangsu Hengrui listed on the Shanghai Stock Exchange (SSE) in 2000, and its CEO Sun Piaoyang and his wife Zhong Huijuan, CEO of Hansoh Pharma, are now among the richest families in China.
adress : No.7 Kunlunshan Road, Lianyungang Eco & Tech Development Zone Lianyungang، Jiangsu Province 222047، CN
Website:http://www.hrs.com.cn/index.html